Pipeline Review of Rheumatoid Arthritis Drugs Market Set to Record Exponential Growth by 2024
Rheumatoid arthritis (RA) is an inflammatory and systemic form of arthritis that results in joint pain, inflammation, stiffness, and swelling. The rising prevalence of RA is one of the primary factors escalating the development of drugs for their treatment. About 4.9 million people across the major markets are suffering from this disorder. Prior to 1998, there were limited treatment options. The new treatment strategies available currently focus on early stage diagnosis, aggressive treatment, and continuous monitoring that have aided many...
View full press release